The Healthy Communities Grant Program is seeking projects that: • Target resources to benefit communities at risk (environmental justice areas of potential concern, places with high risk from toxic air pollution, urban areas) and sensitive populations (e.g. children, elderly, others at increased risk). • Assess, understand, and reduce environmental and human health risks. • Increase collaboration through community-based projects. • Build institutional and community capacity to understand and solve environment and human health problems. • Achieve measurable environmental and human health benefits. Proposed projects must: (1) Be located in and/or directly benefit one or more of the three Target Investment Areas which include: Environmental Justice Areas of Potential Concern, Sensitive Populations, and/or Urban Areas in one or more of the EPA Region I States of Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, and/or Vermont; and (2) Identify how the proposed project will achieve measurable environmental and/or public health results in one or more of the five Target Program Areas which include Asthma, Capacity Building on Environmental and Public Health Issues, Healthy Indoor/Outdoor Environments, Healthy Schools, Urban Natural Resources. Funding Opportunity Number: EPA-R1-HC-2010. Assistance Listing: 66.110. Funding Instrument: CA. Category: ENV. Award Amount: $5K – $35K per award.

Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), invites Small Business Innovation Research (SBIR) cooperative agreement applications from small business concerns (SBCs) that propose to develop new, or to improve existing application(s) of nanotechnology-based therapeutics or/and in vivo diagnostics. This FOA will specifically support pre-clinical optimization and testing of these cancer-relevant nanotechnology applications against the intended cancer type. The proposed projects must be milestone-driven and must be clearly directed toward development of an ultimate commercial product. The outcomes are expected to advance the discovery and pre-clinical optimization phase so that an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application could be submitted to the Food and Drug Administration (FDA) by the end or shortly after completion of the Phase II project period. To facilitate these steps, the NCI will assist the awardees in various ways, including the support through the NCI-sponsored Nanotechnology Characterization Laboratory. This FOA will NOT support basic research projects, studies on disease mechanisms, and clinical trials. Mechanism of Support. This FOA will utilize the SBIR (U43/U44) cooperative agreement mechanisms for Phase I and Phase II applications. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. Funding Opportunity Number: PAR-10-286. Assistance Listing: 93.393,93.394,93.395,93.396. Funding Instrument: CA. Category: ED,HL. Award Amount: Up to $150K per award.

The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from small business concerns (SBCs) to the newly re-authorized Commercialization Readiness Pilot (CRP) program. The FOA aims to facilitate the transition of previously funded SBIR and STTR Phase II and Phase IIB projects to the commercialization stage by providing additional support for technical assistance not typically supported through Phase II or Phase IIB grants or contracts. This may include preparation of documents for a Food and Drug Administration (FDA) submission, development of an intellectual property strategy, and/or planning for a clinical trial. Although a significant amount of the work in a CRP award may be subcontracted to other organizations, the SBC is expected to maintain oversight and management of the R and D throughout the award. Clinical trials not accepted under this FOA. Funding Opportunity Number: PAR-19-334. Assistance Listing: 93.113,93.121,93.172,93.173,93.233,93.242,93.273,93.286,93.350,93.393,93.394,93.395,93.396,93.399,93.837,93.838,93.839,93.840,93.846,93.847,93.855,93.859,93.866,93.867. Funding Instrument: G. Category: ED,ENV,FN,HL.

Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed) is sponsored by National Cancer Institute (NCI). This NOFO encourages applications promoting transformative discoveries in cancer biology and/or oncology through the use of nanotechnology. It specifically mentions the integration of modeling and simulation approaches to guide rational nanomaterial design and the use of artificial intelligence (AI) and modeling to aid rational drug design. This directly relates to personalized medicine and cancer treatment, though the primary focus is nanotechnology.

The importance of prevention in combatting the opioid crisis is clear identifying and implementing effective strategies to prevent the onset of opioid misuse and use disorder and reducing the need to treat disorders yields positive individual, societal, and financial benefits. In 2020, 9.5 million people aged 12 or older misused opioids in the past year (NSDUH, 2021), suggesting that there are millions of people whose trajectories could have been changed, had they been exposed to an effective prevention strategy. Currently funded HEAL studies are testing whether existing programs shown to prevent or treat non-opioid substance use disorders might generalize to opioids. However, there remain many gaps in knowledge about how to deploy prevention services. Often effective strategies are not adopted, implemented, or scaled-up, limiting their reach and impact. There is a critical need for research to develop innovative strategies to implement and sustain prevention services that are affordable, practical, sustainable, and designed in partnership with end-users. To address these gaps, we propose an RFA with multiple receipt dates calling for investigator-initiated research that will address priorities in the implementation and sustainability of prevention services, and the creation of a prevention infrastructure. Funding Opportunity Number: RFA-DA-24-067. Assistance Listing: 93.213,93.279,93.866. Funding Instrument: G. Category: ED,HL.

This Brain-Behavior Quantification and Synchronization notice of funding opportunity (NOFO) seeks applications that bring together transdisciplinary teams and aim to 1) develop, validate, and apply cutting-edge tools and methods for minimally invasive, multi-dimensional, high-resolution objective measurement of behavior at the organismal level, with synchronous capture of dynamic environmental data; 2) develop advanced analytic approaches to integrate multidimensional behavioral, neural and environmental data; and 3) develop and test new theoretical and computational models aiming to advance understanding of behavior as a complex dynamic system. Proposed projects are expected to be designed with the capacity to integrate synchronously recorded neural data and/or inform existing models of neurobehavioral function, such as those developed with the support of the NIH BRAIN Initiative.This BRAIN Initiative NOFO is specifically soliciting applications proposing basic research involving human subjects aiming to reveal and understand fundamental principles underlying behavioral function, including research limited to observational studies or analysis of human data. Applications proposing research using exclusively non-human animal models should apply under the companion NOFO, RFA-DA-24-041. Funding Opportunity Number: RFA-DA-24-040. Assistance Listing: 93.213,93.242,93.273,93.279,93.286,93.853,93.865,93.866,93.867. Funding Instrument: CA. Category: ED,HL,ISS.

Drinking Water State Revolving Fund (DWSRF) is a financial assistance program from NYS EFC and NYS Department of Health providing low-interest loans and grants to upgrade drinking water infrastructure in New York State. Eligible borrowers include community water systems and nonprofit non-community water systems. Projects must be listed on the Department of Health's Intended Use Plan (IUP) before applying. The program prioritizes projects addressing public health risks, aging infrastructure, and emerging contaminant compliance, with enhanced funding available through the Infrastructure Investment and Jobs Act.

NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.

Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF). This interagency solicitation is a collaboration between NSF and NIH, supporting innovative, high-risk/high-reward research with the promise of disruptive transformations in biomedical and public health research. It encourages well-coordinated, convergent, and interdisciplinary approaches drawing from multiple domains of computer and information science, engineering, mathematical sciences, and the biomedical, social, behavioral, and economic sciences.

Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) / National Institutes of Health (NIH). This interagency solicitation supports innovative, high-risk/high-reward research that uses convergent and interdisciplinary approaches from computer and information science, engineering, mathematical sciences, and biomedical, social, behavioral, and economic sciences to address challenges in biomedical and public health research. AI in interventional radiology fits well within this scope.

Community Mental Health Services Block Grant is sponsored by SAMHSA. SAMHSA awards supplemental funding through the Community Mental Health Services Block Grant for efforts to address the intersection of homelessness and serious mental illness (SMI), providing an opportunity for states to align public health, housing, and justice systems to reduce homelessness and improve outcomes. This includes building capacity and promoting collaboration across systems to support individuals with SMI.

The purpose of this Notice of Funding Opportunity (NOFO) is to support a Human Tissue and Organ Research Resource program to enable the continued availability of human tissues and organs to biomedical researchers. The overall goal of the research resource is to provide a wide variety of human tissues and organs, both diseased and normal, to investigators. The research resource is expected to facilitate the procurement and preservation of human tissues and organs as well as the distribution of these materials to qualified biomedical researchers. Funding Opportunity Number: PAR-24-258. Assistance Listing: 93.173,93.233,93.351,93.837,93.838,93.839,93.840,93.846,93.847,93.855,93.867. Funding Instrument: CA. Category: FN,HL.

BrightFocus Foundation Alzheimer's Disease Research Grants is a grant from BrightFocus Foundation that funds pioneering biomedical research aimed at understanding, preventing, and treating Alzheimer's disease. The program supports both U.S. domestic and international researchers conducting early-stage and translational research across the stages of discovery. Priority areas include molecular mechanisms of disease, novel therapeutic targets, and clinical interventions. Eligible applicants include scientists and institutions worldwide. Awards support multi-year research projects, with funding levels and deadlines announced annually via a Request for Proposals.

Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) and National Institutes of Health (NIH). This interagency program supports innovative, high-risk/high-reward research with the promise of disruptive transformations in biomedical and public health research. It focuses on interdisciplinary AI and data science for biomedical challenges, telehealth analytics, and remote monitoring. The work must make fundamental contributions to two or more disciplines, such as computer or information sciences, engineering, mathematical sciences, and the biomedical, social, behavioral, and economic sciences, addressing a key health problem.

Innovation Grant is a grant from the Delta Dental of Arizona Foundation that funds nonprofit organizations pursuing unique, high-impact projects that improve health and wellness in Arizona communities. This two-year award supports original initiatives with measurable real-world impact, including programs serving underserved and uninsured populations through oral health education, disease prevention, and nutritional access. Projects must demonstrate the potential to make a meaningful difference in the community and stand apart from conventional approaches. Eligible applicants are Arizona-based nonprofit organizations. Awards total $100,000 per recipient over two years. The 2026 application cycle closed October 16, 2025, with recipients notified in late 2025 and funding made available shortly after.

NICHD Small Research Grant Program (R03 Basic Experimental Studies with Humans Required) is sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Supports clinical trials that prospectively assign human participants to conditions to assess biomedical or behavioral outcomes, focusing on fundamental aspects of phenomena without specific application towards processes or products in mind.

The NEI uses this U44 Notice of Funding Opportunity to support SBIR grant applications from small business concerns (SBCs) that propose to implement investigator-initiated, early-stage clinical trials with greater than minimal risk and typically are Phase I or II trials. The risk level of the U44 trial requires appropriate performance oversight and safety monitoring. For purposes of this NOFO, the proposed study must be intended to evaluate interventions aimed at screening, diagnosing, preventing, or treating vision disorders.Applicants are strongly advised to consult with NEI program staff prior to submitting an application with human subjects to determine the appropriate funding opportunity. Funding Opportunity Number: PAR-24-066. Assistance Listing: 93.867. Funding Instrument: CA. Category: HL.

Through this Notice of Funding Opportunity (NOFO), the National Institutes of Health (NIH) aims to facilitate the career development and transition of investigators new to entrepreneurship with an interest in small business by simultaneously supporting their entrepreneurial development and the conduct of research and development under their direction.This NOFO supports small business concerns (SBCs) in employing and developing researchers as entrepreneurial Program Directors/Principal Investigators (PDs/PIs). In addition to augmenting scientific research staff and supporting research and development efforts at SBCs, a major component of this NOFO is entrepreneurial training, mentoring, and career development of the PD/PI. Optimal PDs/PIs for this award are scientists and professionals with strong research, technology development, and/or healthcare delivery skills and experience, but limited entrepreneurial and independent research project leadership experience. PDs/PIs are expected to grow their entrepreneurial skillset while working in a small business to develop promising technologies and products that align with NIH's mission to improve health and save lives. Funding Opportunity Number: PAR-24-133. Assistance Listing: 93.113,93.121,93.172,93.173,93.213,93.233,93.273,93.279,93.350,93.361,93.837,93.838,93.839,93.840,93.846,93.859,93.865,93.866,93.867,93.879. Funding Instrument: G. Category: ED,ENV,HL,ISS.

AAI Public Policy Fellowship is a grant from the American Association of Immunologists (AAI) that empowers early-career biomedical researchers to become effective advocates for science policy and NIH funding. Designed for scientists within 15 years of receiving their terminal degree, this one-year fellowship provides specialized training in public policy, hands-on advocacy experience, and direct engagement with federal lawmakers on Capitol Hill. Fellows participate in monthly virtual meetings, attend the AAI annual meeting, and collaborate with AAI government affairs staff — all without leaving their current position or institution. Ideal for immunologists committed to shaping the future of biomedical research policy.

AQHF Equine Research Grants is a grant from the American Quarter Horse Foundation (AQHF) that funds scientific research focused on the health, welfare, and performance of American Quarter Horses. Supported research areas include equine disease prevention, nutrition, reproduction, genetics, and injury rehabilitation. The program is open to researchers at accredited U.S. universities and research institutions. Proposals are evaluated by a scientific review committee and must demonstrate clear relevance to the Quarter Horse industry. Award amounts vary by project; applications are accepted on an annual cycle with deadlines published on the AQHF website.

Developing Agency, Identity and Belonging in Young People is sponsored by The Colorado Health Foundation. Provides support for programs that offer safe, welcoming spaces for youth (BIPOC, LGBTQIA2S+, etc.) to develop relationships, community connection, and resilience outside of school or home. Geographic focus: Colorado Focus areas: Thriving Young People, Health Equity, Social-Emotional Development

Connected Healthy Lives Grant Cycle is a grant from the Humana Foundation that funds organizations advancing health equity through innovative programs addressing the social determinants of health. The Humana Foundation directs its grantmaking around four core commitment areas, with a Health Equity Innovation Fund supporting bold, transformative approaches. Grants range from $50,000 to $2,500,000, with single-year and multi-year proposals accepted. Applicants must establish an organizational profile and complete an eligibility check through the Humana Foundation's SmartSimple grant management portal before submitting a proposal.

The Bicycle Helmet Initiative is a grant from the North Carolina Department of Transportation that funds organizations distributing free bicycle helmets to promote cyclist safety across the state. The program provides 25 to 100 helmets per recipient, valued at approximately $500 to $2,000. Eligible applicants include North Carolina government entities, nonprofits, schools, churches, and public health agencies committed to bicycle safety education and outreach. The most recent application deadline was February 20, 2026. This initiative supports the state's broader Safe Routes to School and pedestrian and bicycle safety goals by ensuring cost is not a barrier to helmet access for North Carolina communities.

HSIL Hackathon 2026 - Building High-Value Health Systems: Leveraging AI is a grant from the Health Systems Innovation Lab (HSIL) at Harvard T.H. Chan School of Public Health that funds innovators designing technology-powered solutions to strengthen health systems worldwide. Now in its 7th edition, this intensive two-day global event brings together participants to brainstorm, build, and pitch AI-driven prototypes with real pathways to scale. In 2025, the program attracted over 500 teams across 19 hubs globally. Winning teams are invited to join the HSIL Venture Incubation Program, which provides structured educational sessions and mentorship to further develop their solutions. The hackathon is open to all individuals inspired to advance health systems through innovation.

Colorado Energy Efficiency Business Rebate Program is a grant from the Colorado Department of Public Health and Environment that funds energy efficiency upgrades for small businesses in eligible Colorado communities. The program provides rebates for improvements such as LED lighting installations and commercial refrigeration equipment replacement. Awards are available up to $10,000 per business. Initially available in Aurora and Commerce City, with potential expansion to additional communities. Eligible applicants are Colorado-based small businesses operating in participating communities whose projects focus on qualifying energy efficiency upgrades. The program deadline was March 1, 2026.

NSF 25-509: Emerging Mathematics in Biology (eMB) is a grant from NSF that funds integrative research projects applying innovative mathematical theories and techniques to significant biological questions. The program supports truly interdisciplinary work at the interface of mathematics, biology, and public health, encouraging novel use of mathematical tools to advance biological understanding and inform public health policy. Eligible applicants include accredited two- and four-year institutions of higher education with campuses in the United States. Full proposals are due March 1 annually, with total funding ranging from $2 million to $6 million across multiple awards.

The Myelodysplastic Syndromes (MDS) Research Fund is a grant from the Vera and Joseph Dresner Foundation that funds early-career and established investigators conducting research on MDS — a group of blood cancers affecting bone marrow function. The program supports innovative research and clinical trials aimed at improving standards of care for patients. Past awardees include investigators at Johns Hopkins University, Memorial Sloan-Kettering, and H. Lee Moffitt Cancer Center. Eligible applicants are U.S.-based 501(c)(3) institutions (universities, hospitals, or research laboratories); principal investigators must hold a doctoral-level degree (MD, PhD, PharmD, or DO). Early-career awards reach up to ,000 per year; established investigator awards up to ,000 over two years. The deadline was March 6, 2026.

The Maryland Department of Health Addressing Disparities in Social Determinants of Health (SDOH) and Obesity in Maryland Communities Program is a grant from the Maryland Department of Health that funds community-based interventions targeting health disparities, social determinants of health, and obesity among racial and ethnic minorities in Maryland. The program descends from the legacy Minority Outreach and Technical Assistance (MOTA) initiative established in 2001 and focuses on chronic disease prevention, education, and outreach. The FY27 RFA deadline was March 11, 2026. Eligible applicants are organizations providing community-based health interventions to underserved populations in Maryland.

The ASPPH/CDC Public Health Fellowship Program is a grant from the Association of Schools and Programs of Public Health (ASPPH) and the Centers for Disease Control and Prevention (CDC) that provides one-year, mentored training experiences for recent master's or doctoral public health graduates. Open to ASPPH-member school alumni who are U.S. citizens or permanent residents, 15 fellowship positions are available across Health Education and Core Public Health tracks. Fellows work at CDC offices in Atlanta, GA (with hybrid options available), gaining hands-on experience with technical experts and cutting-edge databases. The fellowship can be extended up to three years, equipping the next generation of public health leaders with advanced skills and career-readiness.

AAI Careers in Immunology Fellowship Program is a grant from the American Association of Immunologists (AAI) that supports the career development of early-stage scientists committed to biomedical research. The program provides eligible principal investigators with one year of salary support for a graduate student or postdoctoral trainee in their laboratory. Specialized tracks include a public policy fellowship for postdocs interested in AAI's legislative activities, and a re-entry fellowship for postdocs returning after military service or family medical leave. AAI awarded 13 fellowships in 2023. The fellowship does not cover fringe benefits or indirect costs. Funding is approximately ,630 per award, with a deadline of March 15, 2026.